
Anne Marie Sabrina Wehbe
Examiner (ID: 18312)
| Most Active Art Unit | 1633 |
| Art Unit(s) | 1632, 1633, 1634 |
| Total Applications | 1342 |
| Issued Applications | 603 |
| Pending Applications | 239 |
| Abandoned Applications | 542 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 5381691
[patent_doc_number] => 20090193530
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-07-30
[patent_title] => 'Animals, cells and methods for production of detectably-labeled antibodies'
[patent_app_type] => utility
[patent_app_number] => 12/316433
[patent_app_country] => US
[patent_app_date] => 2008-12-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 7502
[patent_no_of_claims] => 53
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0193/20090193530.pdf
[firstpage_image] =>[orig_patent_app_number] => 12316433
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/316433 | Animals, cells and methods for production of detectably-labeled antibodies | Dec 11, 2008 | Abandoned |
Array
(
[id] => 8186810
[patent_doc_number] => 20120115896
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-05-10
[patent_title] => 'ISOGENIC HUMAN CELL LINES COMPRISING MUTATED CANCER ALLELES AND PROCESS USING THE CELL LINES'
[patent_app_type] => utility
[patent_app_number] => 13/132737
[patent_app_country] => US
[patent_app_date] => 2008-12-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 25
[patent_figures_cnt] => 25
[patent_no_of_words] => 21326
[patent_no_of_claims] => 30
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0115/20120115896.pdf
[firstpage_image] =>[orig_patent_app_number] => 13132737
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/132737 | ISOGENIC HUMAN CELL LINES COMPRISING MUTATED CANCER ALLELES AND PROCESS USING THE CELL LINES | Dec 2, 2008 | Abandoned |
Array
(
[id] => 8340328
[patent_doc_number] => 08242253
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2012-08-14
[patent_title] => 'Nucleotide sequence of shrimp actin promoter and its use in genetic transformation biotechnology'
[patent_app_type] => utility
[patent_app_number] => 12/274627
[patent_app_country] => US
[patent_app_date] => 2008-11-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 10
[patent_figures_cnt] => 12
[patent_no_of_words] => 11076
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 30
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12274627
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/274627 | Nucleotide sequence of shrimp actin promoter and its use in genetic transformation biotechnology | Nov 19, 2008 | Issued |
Array
(
[id] => 8630152
[patent_doc_number] => 08362223
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2013-01-29
[patent_title] => 'Hemopoietin receptor protein, NR10'
[patent_app_type] => utility
[patent_app_number] => 12/253506
[patent_app_country] => US
[patent_app_date] => 2008-10-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 14
[patent_figures_cnt] => 14
[patent_no_of_words] => 23188
[patent_no_of_claims] => 32
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 39
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12253506
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/253506 | Hemopoietin receptor protein, NR10 | Oct 16, 2008 | Issued |
Array
(
[id] => 6549751
[patent_doc_number] => 20100233144
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-09-16
[patent_title] => 'METHOD FOR OPTIMIZING BLOOD CELL TRANSPLANTS'
[patent_app_type] => utility
[patent_app_number] => 12/682643
[patent_app_country] => US
[patent_app_date] => 2008-10-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 4216
[patent_no_of_claims] => 23
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0233/20100233144.pdf
[firstpage_image] =>[orig_patent_app_number] => 12682643
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/682643 | METHOD FOR OPTIMIZING BLOOD CELL TRANSPLANTS | Oct 9, 2008 | Abandoned |
Array
(
[id] => 5952218
[patent_doc_number] => 20110033388
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-02-10
[patent_title] => 'IMAGEABLE RODENT MODEL OF ASTHMA'
[patent_app_type] => utility
[patent_app_number] => 12/681348
[patent_app_country] => US
[patent_app_date] => 2008-10-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 11
[patent_figures_cnt] => 11
[patent_no_of_words] => 7228
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0033/20110033388.pdf
[firstpage_image] =>[orig_patent_app_number] => 12681348
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/681348 | IMAGEABLE RODENT MODEL OF ASTHMA | Sep 30, 2008 | Abandoned |
Array
(
[id] => 5435026
[patent_doc_number] => 20090169612
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-07-02
[patent_title] => 'Systemic Immune Activation Method Using Nucleic Acid-Lipid Complexes'
[patent_app_type] => utility
[patent_app_number] => 12/242526
[patent_app_country] => US
[patent_app_date] => 2008-09-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 33
[patent_figures_cnt] => 33
[patent_no_of_words] => 29478
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0169/20090169612.pdf
[firstpage_image] =>[orig_patent_app_number] => 12242526
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/242526 | Systemic Immune Activation Method Using Nucleic Acid-Lipid Complexes | Sep 29, 2008 | Abandoned |
Array
(
[id] => 5571623
[patent_doc_number] => 20090255002
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-10-08
[patent_title] => 'Transgenic Non-Human Animals For Producing Chimeric Antibodies'
[patent_app_type] => utility
[patent_app_number] => 12/239523
[patent_app_country] => US
[patent_app_date] => 2008-09-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 101
[patent_figures_cnt] => 101
[patent_no_of_words] => 90274
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 8
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0255/20090255002.pdf
[firstpage_image] =>[orig_patent_app_number] => 12239523
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/239523 | Transgenic non-human animals for producing chimeric antibodies | Sep 25, 2008 | Issued |
Array
(
[id] => 8114415
[patent_doc_number] => 08158419
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2012-04-17
[patent_title] => 'Transgenic non-human animals for producing chimeric antibodies'
[patent_app_type] => utility
[patent_app_number] => 12/239493
[patent_app_country] => US
[patent_app_date] => 2008-09-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 100
[patent_figures_cnt] => 116
[patent_no_of_words] => 89957
[patent_no_of_claims] => 2
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 161
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/08/158/08158419.pdf
[firstpage_image] =>[orig_patent_app_number] => 12239493
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/239493 | Transgenic non-human animals for producing chimeric antibodies | Sep 25, 2008 | Issued |
Array
(
[id] => 5322853
[patent_doc_number] => 20090060843
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-03-05
[patent_title] => 'Non-Invasive In Vivo Imaging and Methods for Treating Type I Diabetes'
[patent_app_type] => utility
[patent_app_number] => 12/199473
[patent_app_country] => US
[patent_app_date] => 2008-08-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 11990
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0060/20090060843.pdf
[firstpage_image] =>[orig_patent_app_number] => 12199473
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/199473 | Non-Invasive In Vivo Imaging and Methods for Treating Type I Diabetes | Aug 26, 2008 | Abandoned |
Array
(
[id] => 7573055
[patent_doc_number] => 20110268711
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-11-03
[patent_title] => 'PANCREATIC STELLATE CELL SPECIFIC PROMOTER AND USES THEREOF'
[patent_app_type] => utility
[patent_app_number] => 12/674414
[patent_app_country] => US
[patent_app_date] => 2008-08-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 10904
[patent_no_of_claims] => 27
[patent_no_of_ind_claims] => 9
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0268/20110268711.pdf
[firstpage_image] =>[orig_patent_app_number] => 12674414
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/674414 | PANCREATIC STELLATE CELL SPECIFIC PROMOTER AND USES THEREOF | Aug 20, 2008 | Abandoned |
Array
(
[id] => 8629906
[patent_doc_number] => 08361978
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2013-01-29
[patent_title] => 'Use of herpes vectors for tumor therapy'
[patent_app_type] => utility
[patent_app_number] => 12/194872
[patent_app_country] => US
[patent_app_date] => 2008-08-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 11
[patent_figures_cnt] => 13
[patent_no_of_words] => 9552
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 109
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12194872
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/194872 | Use of herpes vectors for tumor therapy | Aug 19, 2008 | Issued |
Array
(
[id] => 11720698
[patent_doc_number] => 09693539
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2017-07-04
[patent_title] => 'HCO32 and HCO27 and related examples'
[patent_app_type] => utility
[patent_app_number] => 12/672883
[patent_app_country] => US
[patent_app_date] => 2008-08-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 9
[patent_no_of_words] => 27789
[patent_no_of_claims] => 7
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 81
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12672883
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/672883 | HCO32 and HCO27 and related examples | Aug 7, 2008 | Issued |
Array
(
[id] => 5521370
[patent_doc_number] => 20090029351
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-01-29
[patent_title] => 'METHOD OF MEASURING HUMAN CYP3A INDUCIBILITY'
[patent_app_type] => utility
[patent_app_number] => 12/180822
[patent_app_country] => US
[patent_app_date] => 2008-07-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 11
[patent_figures_cnt] => 11
[patent_no_of_words] => 4544
[patent_no_of_claims] => 4
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0029/20090029351.pdf
[firstpage_image] =>[orig_patent_app_number] => 12180822
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/180822 | METHOD OF MEASURING HUMAN CYP3A INDUCIBILITY | Jul 27, 2008 | Abandoned |
Array
(
[id] => 7740160
[patent_doc_number] => 08105832
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2012-01-31
[patent_title] => 'Methods for modifying stem cell characteristics'
[patent_app_type] => utility
[patent_app_number] => 12/176647
[patent_app_country] => US
[patent_app_date] => 2008-07-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 4
[patent_no_of_words] => 2944
[patent_no_of_claims] => 4
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 62
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/08/105/08105832.pdf
[firstpage_image] =>[orig_patent_app_number] => 12176647
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/176647 | Methods for modifying stem cell characteristics | Jul 20, 2008 | Issued |
Array
(
[id] => 7976677
[patent_doc_number] => 08071085
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2011-12-06
[patent_title] => 'Primary cultured adipocytes for gene therapy'
[patent_app_type] => utility
[patent_app_number] => 12/175186
[patent_app_country] => US
[patent_app_date] => 2008-07-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 16
[patent_figures_cnt] => 16
[patent_no_of_words] => 13332
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 111
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/08/071/08071085.pdf
[firstpage_image] =>[orig_patent_app_number] => 12175186
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/175186 | Primary cultured adipocytes for gene therapy | Jul 16, 2008 | Issued |
Array
(
[id] => 4852001
[patent_doc_number] => 20080317743
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-12-25
[patent_title] => 'Human Artificial Chromosome Containing Human Antibody Lambda Light Chain Gene And Non-Human Animal Containing The Human Artificial Chromosome Capable Of Genetic Transmission'
[patent_app_type] => utility
[patent_app_number] => 12/140009
[patent_app_country] => US
[patent_app_date] => 2008-06-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 15184
[patent_no_of_claims] => 33
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0317/20080317743.pdf
[firstpage_image] =>[orig_patent_app_number] => 12140009
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/140009 | Human artificial chromosome containing human antibody λ light chain gene and non-human animal containing the human artificial chromosome capable of genetic transmission | Jun 15, 2008 | Issued |
Array
(
[id] => 5367855
[patent_doc_number] => 20090305414
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-12-10
[patent_title] => 'Methods Of Tissue Engineering'
[patent_app_type] => utility
[patent_app_number] => 12/136543
[patent_app_country] => US
[patent_app_date] => 2008-06-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 3912
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0305/20090305414.pdf
[firstpage_image] =>[orig_patent_app_number] => 12136543
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/136543 | Methods of tissue engineering | Jun 9, 2008 | Issued |
Array
(
[id] => 9113398
[patent_doc_number] => 08569573
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2013-10-29
[patent_title] => 'Method of expanding human hepatocytes in vivo'
[patent_app_type] => utility
[patent_app_number] => 12/663219
[patent_app_country] => US
[patent_app_date] => 2008-06-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 17
[patent_figures_cnt] => 51
[patent_no_of_words] => 17558
[patent_no_of_claims] => 27
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 46
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12663219
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/663219 | Method of expanding human hepatocytes in vivo | Jun 4, 2008 | Issued |
Array
(
[id] => 4710646
[patent_doc_number] => 20080299172
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-12-04
[patent_title] => 'TISSUE REPAIR IMPLANT'
[patent_app_type] => utility
[patent_app_number] => 12/132557
[patent_app_country] => US
[patent_app_date] => 2008-06-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 2106
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0299/20080299172.pdf
[firstpage_image] =>[orig_patent_app_number] => 12132557
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/132557 | TISSUE REPAIR IMPLANT | Jun 2, 2008 | Abandoned |